Dr. Jennifer Bath, an expert in antibody discovery, as well as translational work in infectious disease, explains why leaving a tenured professorship was a price worth paying to become the CEO of ImmunoPrecise Antibodies (IPA...

Cortexyme CEO, Casey Lynch, discusses her life-long passion for finding treatments for neurodegenerative diseases in general, and Alzheimer’s in particular. She tells how her experience over the years, in different labs, and ...

Medigene CEO, Dolores Schendel, takes us from her Midwestern roots to the helm of Bavaria’s Medigene AG. Along the way, she explains how her training at the hands of immunotherapy pioneers led to her recent move to deploy a n...

Dr. Coffey explains how a phenomenon first observed over a 100 years ago – that a systemic infection can cure cancer – became the blanket term for a treatment modality bearing his company’s name. From being a lab rat studying...

BiomX co-founder, Jonathan Solomon, gained his early scientific training in physics, and electrical engineering during a ten-year stint in an Israeli army special forces unit – which he can’t really talk about. But what he ca...

Dr. Caligiuri describes his journey from being a liberal arts major at a college in upstate New York, to being a Stanford trained MD, to his current position as President of City of Hope National Medical Center. Along the way...